Investment Stage

Focus Areas

About Investor

Liam Maniscalco is an Investor at F-Prime Capital Partners focused on biotechnology investments. Based in the San Francisco Bay Area, he evaluates emerging biotech companies across Seed, Series A, and Series B stages. His interests include innovative therapeutic platforms, drug development programs, and technologies advancing human health. Liam works with founders and scientific teams to identify opportunities capable of producing significant clinical impact. He participates in investment rounds ranging from $500,000 to $10 million, with an average check size around $5 million. Entrepreneurs building cutting-edge biotech solutions may find strong alignment with his investment interests.